Nephrol Dial Transplant (2002) 17: 1457-1462
© 2002 European Renal Association-European Dialysis and Transplant Association
Sonoclot coagulation analysis: new bedside monitoring for determination of the appropriate heparin dose during haemodialysis
Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
Background. Thrombotic and haemorrhagic complications affect cardiovascular morbidity and mortality in haemodialysis patients. We investigated whether a new bedside Sonoclot analysis is useful for determining an appropriate heparin dose during haemodialysis.
Methods. Twenty-two haemodialysis patients (15 males and seven females) treated with unfractionated heparin were recruited. Sonoclot parameters, including activated clotting time (ACT), clot rate (CR), time to peak (TP) and peak amplitude (PA), were examined before and after haemodialysis, coupled with conventional coagulable variables, platelet count and fibrinogen level. Some indices were determined and verified to control heparin dose. Thrombotic and haemorrhagic complications were observed for 3 months. Sonoclot analysis was subsequently performed before initiation, 1 h later, 2.5 or 3 h later (before cessation of heparin infusion), and at the end of haemodialysis.
Results. Both CR and PA were positively correlated with platelet count and fibrinogen level. Sonoclot parameters except for PA were significantly correlated with heparin dose. Heparin dose was reduced without causing complications in 12 patients with 
ACT 
40 s and/or CR after haemodialysis (CRpost) <20 U/min. Thrombotic complications occurred in five patients who had CRpost >30 U/min. ACT and TP increased during heparin treatment. ACT was reversed but TP did not change after cessation of heparin. CR significantly decreased after initiation of heparin and was reversed, although not completely, after cessation of heparin. PA showed no significant changes during haemodialysis.
Conclusions. Sonoclot analysis can monitor accurate coagulable states and determine an appropriate heparin dose during haemodialysis.
Keywords: coagulation; haemodialysis; heparin; Sonoclot analysis
Correspondence and offprint requests to: Masato Furuhashi, Second Department of Internal Medicine, Sapporo Medical University School of Medicine, S-1, W-16, Chuo-ku, Sapporo 060-8543, Japan. Email: furuhasi{at}sapmed.ac.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T J Coats, E Brazil, M Heron, and P K MacCallum Impairment of coagulation by commonly used resuscitation fluids in human volunteers. Emerg. Med. J., November 1, 2006; 23(11): 846 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T J Coats, E Brazil, and M Heron The effects of commonly used resuscitation fluids on whole blood coagulation. Emerg. Med. J., July 1, 2006; 23(7): 546 - 549. [Abstract] [Full Text] [PDF]
|
|